Cite
Molecular docking, 3D-QSAR, molecular dynamics, synthesis and anticancer activity of tyrosine kinase 2 (TYK 2) inhibitors.
MLA
Itteboina, Ramesh, et al. “Molecular Docking, 3D-QSAR, Molecular Dynamics, Synthesis and Anticancer Activity of Tyrosine Kinase 2 (TYK 2) Inhibitors.” Journal of Receptor and Signal Transduction Research, vol. 38, no. 5–6, Oct. 2018, pp. 462–74. EBSCOhost, https://doi.org/10.1080/10799893.2019.1585453.
APA
Itteboina, R., Ballu, S., Sivan, S. K., & Manga, V. (2018). Molecular docking, 3D-QSAR, molecular dynamics, synthesis and anticancer activity of tyrosine kinase 2 (TYK 2) inhibitors. Journal of Receptor and Signal Transduction Research, 38(5–6), 462–474. https://doi.org/10.1080/10799893.2019.1585453
Chicago
Itteboina, Ramesh, Srilata Ballu, Sree Kanth Sivan, and Vijjulatha Manga. 2018. “Molecular Docking, 3D-QSAR, Molecular Dynamics, Synthesis and Anticancer Activity of Tyrosine Kinase 2 (TYK 2) Inhibitors.” Journal of Receptor and Signal Transduction Research 38 (5–6): 462–74. doi:10.1080/10799893.2019.1585453.